Fact based stock research
Hill-Rom (NYSE:HRC)


Hill-Rom stock research in summary

hill-rom.com


Hill-Rom shares have a BUY rating. They are good value and show above average growth, but are riskily financed. We recommend buying and holding Hill-Rom shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Equipment
Index S&P MIDCAP, D.J. US Medical Equipment
Size class Large

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock






 

Research History: Hill-Rom

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
43
41
80
84
STOCK GROWTH RANKS
76
96
37
68
STOCK SAFETY RANKS
3
1
12
37
COMBINED STOCK RANKS
31
54
47
74

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Hill-Rom in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Hill-Rom; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
76
97
31
44
PROFIT GROWTH
19
77
35
46
STOCK RETURNS
41
60
55
84
CONSOLIDATED RANK: GROWTH
76
96
37
68

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Hill-Rom.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
6
8
10
10
REFINANCING
73
64
LIQUIDITY
18
19
62
41
CONSOLIDATED RANK: SAFETY
3
1
12
37

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Hill-Rom and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Hill-Rom from March 22, 2018.